Zobrazeno 1 - 10 of 19 pro vyhledávání: '"Dl, Petersen"'
2
Akademický článek
Analyzing functional heterogeneity of effector cells for enhanced adoptive cell therapy applications.
Autor: Kiel Rasmussen AC; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.; Samplix ApS, Birkerød, Denmark., Hulen TM; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Petersen DL; Samplix ApS, Birkerød, Denmark., Jacobsen MJ; Samplix ApS, Birkerød, Denmark., Mikkelsen MJ; Samplix ApS, Birkerød, Denmark., Met Ö; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Donia M; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Chamberlain CA; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Mouritzen P; Samplix ApS, Birkerød, Denmark.
Publikováno v: Immuno-oncology technology [Immunooncol Technol] 2024 Sep 25; Vol. 24, pp. 100738. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Zobrazit plný text záznamu
3
Akademický článek
Changes in Vertebral Artery Blood Flow in Different Head Positions and Post-Cervical Manipulative Therapy.
Autor: Yelverton C; Department of Chiropractic, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa.. Electronic address: chrisy@uj.ac.za., Wood JJ; Department of Chiropractic, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa., Petersen DL; Department of Chiropractic, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa., Peterson C; Department of Chiropractic, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa.
Publikováno v: Journal of manipulative and physiological therapeutics [J Manipulative Physiol Ther] 2020 Feb; Vol. 43 (2), pp. 144-151. Date of Electronic Publication: 2020 May 30.
Zobrazit plný text záznamu
4
Akademický článek
Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome.
Autor: Hu T; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Buus TB; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Krejsgaard T; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Nansen A; Department of Molecular Pharmacology, Zealand Pharma A/S, Glostrup, Denmark., Lundholt BK; Department of Molecular Pharmacology, Zealand Pharma A/S, Glostrup, Denmark., Spee P; PS Pharmaconsult, Allerød, Denmark., Fredholm S; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Petersen DL; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Blümel E; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Gluud M; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Monteiro MN; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Willerslev-Olsen A; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Andersen MH; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital at Herlev, Copenhagen, Denmark., Straten PT; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital at Herlev, Copenhagen, Denmark., Met Ö; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital at Herlev, Copenhagen, Denmark., Stolearenco V; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Fogh H; Department of Dermatology, Copenhagen University Hospital at Bispebjerg, Copenhagen, Denmark., Gniadecki R; Department of Dermatology, Copenhagen University Hospital at Bispebjerg, Copenhagen, Denmark., Nastasi C; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Litman T; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Woetmann A; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Gjerdrum LMR; Department of Pathology, Zealand University Hospital, Roskilde, Denmark., Ødum N; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Publikováno v: Oncotarget [Oncotarget] 2019 Aug 06; Vol. 10 (47), pp. 4894-4906. Date of Electronic Publication: 2019 Aug 06 (Print Publication: 2019).
Zobrazit plný text záznamu
5
Akademický článek
SATB1 in Malignant T Cells.
Autor: Fredholm S; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Willerslev-Olsen A; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Met Ö; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Kubat L; Translational Skin Cancer Research, German Cancer Consortium (DKTK and DKFZ), Partner Site Essen, Essen, Germany., Gluud M; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Mathiasen SL; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Friese C; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Blümel E; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Petersen DL; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Hu T; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Nastasi C; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Lindahl LM; Department of Dermatology, Aarhus University Hospital, Skejby, Aarhus, Denmark., Buus TB; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Krejsgaard T; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Wasik MA; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kopp KL; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Koralov SB; Department of Pathology, New York University School of Medicine, New York, New York, USA., Persson JL; Division of Experimental Cancer Research, Department of Translational Medicine, Lund University, Clinical Research Centre, Malmö, Sweden; Division of Basal Tumor Biology, Department of Molecular Biology, Umeå University, Umeå, Sweden., Bonefeld CM; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Geisler C; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Woetmann A; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Iversen L; Department of Dermatology, Aarhus University Hospital, Skejby, Aarhus, Denmark., Becker JC; Translational Skin Cancer Research, German Cancer Consortium (DKTK and DKFZ), Partner Site Essen, Essen, Germany. Electronic address: j.becker@dkfz-heidelberg.de., Ødum N; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. Electronic address: ndum@sund.ku.dk.
Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2018 Aug; Vol. 138 (8), pp. 1805-1815. Date of Electronic Publication: 2018 May 08.
Zobrazit plný text záznamu
6
Akademický článek
NCAM2 Fibronectin type-III domains form a rigid structure that binds and activates the Fibroblast Growth Factor Receptor.
Autor: Rasmussen KK; Biological Chemistry, Department of Chemistry, University of Copenhagen, Copenhagen, Denmark. kkr@chem.ku.dk.; Laboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark. kkr@chem.ku.dk.; Structural Biology and NMR Laboratory, Department of Biology, University of Copenhagen, Copenhagen, Denmark. kkr@chem.ku.dk., Falkesgaard MH; Laboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Winther M; Laboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Roed NK; Laboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Quistgaard CL; Laboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Teisen MN; Laboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Edslev SM; Laboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Petersen DL; Laboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Aljubouri A; Laboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Christensen C; Laboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Thulstrup PW; Biological Chemistry, Department of Chemistry, University of Copenhagen, Copenhagen, Denmark., Lo Leggio L; Biological Chemistry, Department of Chemistry, University of Copenhagen, Copenhagen, Denmark., Teilum K; Structural Biology and NMR Laboratory, Department of Biology, University of Copenhagen, Copenhagen, Denmark., Walmod PS; Laboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Publikováno v: Scientific reports [Sci Rep] 2018 Jun 12; Vol. 8 (1), pp. 8957. Date of Electronic Publication: 2018 Jun 12.
Zobrazit plný text záznamu
7
Akademický článek
A novel BLK-induced tumor model.
Autor: Petersen DL; 1 Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Berthelsen J; 1 Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Willerslev-Olsen A; 1 Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Fredholm S; 1 Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Dabelsteen S; 2 Department of Odontology, University of Copenhagen, Copenhagen, Denmark., Bonefeld CM; 1 Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Geisler C; 1 Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Woetmann A; 1 Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Publikováno v: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine [Tumour Biol] 2017 Jul; Vol. 39 (7), pp. 1010428317714196.
Zobrazit plný text záznamu
8
Akademický článek
STAT5 induces miR-21 expression in cutaneous T cell lymphoma.
Autor: Lindahl LM; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark., Fredholm S; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Joseph C; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Nielsen BS; Bioneer A/S, Hørsholm, Denmark., Jønson L; Department of Molecular Medicine, Copenhagen University Hospital, Copenhagen, Denmark., Willerslev-Olsen A; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Gluud M; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Blümel E; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Petersen DL; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Sibbesen N; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Hu T; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Nastasi C; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Krejsgaard T; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Jæhger D; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Persson JL; Clinical Research Center, Lund University, Malmö, Sweden., Mongan N; School of Veterinary Medicine and Science, University of Nottingham, Loughborough, United Kingdom., Wasik MA; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA., Litvinov IV; Division of Dermatology, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada., Sasseville D; Division of Dermatology, McGill University Health Centre, Montréal, Quebec, Canada., Koralov SB; Department of Pathology, New York University School of Medicine, New York, NY, USA., Bonefeld CM; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Geisler C; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Woetmann A; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Ralfkiaer E; Department of Pathology, Copenhagen University Hospital, Copenhagen, Denmark., Iversen L; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark., Odum N; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Publikováno v: Oncotarget [Oncotarget] 2016 Jul 19; Vol. 7 (29), pp. 45730-45744.
Zobrazit plný text záznamu
9
Report
The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma.
Autor: Fredholm S; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark., Litvinov IV; Division of Dermatology, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada., Mongan NP; Faculty of Medicine and Health Sciences School of Veterinary Medicine and Science, School of Medicine, University of Nottingham, Nottingham, UK., Schiele S; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark., Willerslev-Olsen A; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark., Petersen DL; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark., Krejsgaard T; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark., Sibbesen N; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark., Nastasi C; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark., Bonefeld CM; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark., Persson JL; Clinical Research Center, Lund University, Malmö, Sweden., Straten PT; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark., Andersen MH; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark., Koralov SB; Department of Pathology, New York University School of Medicine, New York, New York, USA., Wasik MM; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, USA., Geisler C; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark., Sasseville D; Division of Dermatology, McGill University Health Center, Montréal, Quebec, Canada., Woetmann A; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark., Ødum N; Department of Immunology and Microbiology (ISIM), University of Copenhagen, Copenhagen, Denmark. Electronic address: ndum@sund.ku.dk.
Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2016 Apr; Vol. 136 (4), pp. 866-869. Date of Electronic Publication: 2016 Jan 21.
Zobrazit plný text záznamu
10
Akademický článek
Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.
Autor: Willerslev-Olsen A; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark;, Krejsgaard T; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark;, Lindahl LM; Department of Dermatology, Aarhus University Hospital, Skejby, Aarhus, Denmark;, Litvinov IV; Division of Dermatology, University of Ottawa, Ottawa, ON, Canada;, Fredholm S; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark;, Petersen DL; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark;, Nastasi C; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark;, Gniadecki R; Department of Dermatology, Copenhagen University Hospital, Bispebjerg, Copenhagen, Denmark;, Mongan NP; Faculty of Medicine and Health Science, School of Veterinary Medicine and Science, University of Nottingham, Loughborough, United Kingdom;, Sasseville D; Division of Dermatology, McGill University Health Centre, Montréal, QC, Canada;, Wasik MA; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA;, Bonefeld CM; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark;, Geisler C; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark;, Woetmann A; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark;, Iversen L; Department of Dermatology, Aarhus University Hospital, Skejby, Aarhus, Denmark;, Kilian M; Department of Biomedicine, Aarhus University, Aarhus, Denmark; and., Koralov SB; Department of Pathology, New York University School of Medicine, New York, NY., Odum N; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark;
Publikováno v: Blood [Blood] 2016 Mar 10; Vol. 127 (10), pp. 1287-96. Date of Electronic Publication: 2016 Jan 05.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje